FOXP3 and type 1 diabetes mellitus: The analysis of FoxP3+ cells in the CD25highCD127− gate revealed that the percentage of FoxP3+ cells was significantly decreasing in this gate in untreated patients and in those receiving a single dose of Tregs as T1DM progressed (Fig. 3b).